Founded in 2019 and based in Philadelphia, BioAlert Technologies's mission is develop methodologies to detecting infection in real-time. We are a developmental stage medical device company dedicated to the design and development of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients. BioAlert Technologies enables healthcare providers to make diagnosis and treatment decisions based off of reliable data metrics.